[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100499938":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":32,"responsibleParty":239,"collaborators":10,"id":241,"slug":242,"hasResults":243,"nctId":244,"briefTitle":245,"officialTitle":246,"acronym":10,"eligibilityCriteria":247,"healthyVolunteers":243,"sex":248,"minAge":249,"maxAge":250,"enrollmentInfo":251,"targetDuration":254,"studyType":255,"phases":10,"briefSummary":256,"conditions":257,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":259,"lastUpdatePostDateStruct":260,"startDateStruct":263,"completionDateStruct":265,"leadSponsor":267,"locationsCount":268},{"fullName":5,"class":6},"Biogen","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Nusinersen Treated Participants",null,"Pregnant participants with SMA who are exposed to nusinersen during the relevant window defined as 14 months prior to the first day of the participant's last menstrual period before conception, 14.5 months before conception and anytime during pregnancy and are enrolled in the registries, International Spinal Muscular Atrophy Registry (ISMAR), Adult SMA REACH and SMArtCARE will be followed prospectively up to 3 months post-delivery, the infants will be followed up to 2 years post-delivery and the available data is collected retrospectively.",[13],"Other: No Intervention",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","No Intervention","Administered as specified in the treatment arm.",[9],[21],{"name":22,"affiliation":5,"role":23},"Medical Director","STUDY_DIRECTOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"US Biogen Clinical Trial Center","CONTACT","866-633-4636","clinicaltrials@biogen.com",{"name":31,"role":27,"phone":10,"phoneExt":10,"email":29},"Global Biogen Clinical Trial Center",[33,53,68,78,92,109,120,135,150,165,180,195,210,225],{"facility":34,"status":35,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Stanford Neuroscience Health Center","RECRUITING","Palo Alto","California","94304","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-122.14302,37.44188,{"lat":45,"lon":44},[48,50],{"name":10,"role":27,"phone":49,"phoneExt":10,"email":10},"650-725-7622",{"name":51,"role":52,"phone":10,"phoneExt":10,"email":10},"John W. Day","PRINCIPAL_INVESTIGATOR",{"facility":54,"status":35,"city":55,"state":56,"zip":57,"country":39,"countryCode":40,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Boston Children's Hospital","Boston","Massachusetts","02115",{"type":42,"coordinates":59},[60,61],-71.05977,42.35843,{"lat":61,"lon":60},[64,66],{"name":10,"role":27,"phone":65,"phoneExt":10,"email":10},"617-355-8036",{"name":67,"role":52,"phone":10,"phoneExt":10,"email":10},"Basil T. Darras",{"facility":69,"status":70,"city":71,"state":56,"zip":72,"country":39,"countryCode":40,"cosmosGeoPoint":73,"geoPoint":77,"contacts":10},"Research Site","ACTIVE_NOT_RECRUITING","Cambridge","02142",{"type":42,"coordinates":74},[75,76],-71.10561,42.3751,{"lat":76,"lon":75},{"facility":79,"status":35,"city":80,"state":80,"zip":81,"country":39,"countryCode":40,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"Columbia University Irving Medical Center","New York","10032",{"type":42,"coordinates":83},[84,85],-74.00597,40.71427,{"lat":85,"lon":84},[88,90],{"name":10,"role":27,"phone":89,"phoneExt":10,"email":10},"212-305-1319",{"name":91,"role":52,"phone":10,"phoneExt":10,"email":10},"Michio Hirano",{"facility":93,"status":35,"city":94,"state":95,"zip":96,"country":97,"countryCode":98,"cosmosGeoPoint":99,"geoPoint":103,"contacts":104},"University College London Hospitals NHS Foundation Trust","London","Greater London","NW1 2PG","United Kingdom","UK",{"type":42,"coordinates":100},[101,102],-0.12574,51.50853,{"lat":102,"lon":101},[105,107],{"name":10,"role":27,"phone":106,"phoneExt":10,"email":10},"020 3456 7890",{"name":108,"role":52,"phone":10,"phoneExt":10,"email":10},"Matt Parton",{"facility":110,"status":35,"city":94,"state":95,"zip":111,"country":97,"countryCode":98,"cosmosGeoPoint":112,"geoPoint":114,"contacts":115},"St George's University NHS Foundation Trust","SW17 0QT",{"type":42,"coordinates":113},[101,102],{"lat":102,"lon":101},[116,118],{"name":10,"role":27,"phone":117,"phoneExt":10,"email":10},"020 8672 1255",{"name":119,"role":52,"phone":10,"phoneExt":10,"email":10},"Clare Galtrey",{"facility":121,"status":35,"city":122,"state":123,"zip":124,"country":97,"countryCode":98,"cosmosGeoPoint":125,"geoPoint":129,"contacts":130},"The Northern Care Alliance NHS Foundation Trust","Salford","Greater Manchester","M6 8HD",{"type":42,"coordinates":126},[127,128],-2.29042,53.48771,{"lat":128,"lon":127},[131,133],{"name":10,"role":27,"phone":132,"phoneExt":10,"email":10},"0161 789 7373",{"name":134,"role":52,"phone":10,"phoneExt":10,"email":10},"James Lilleker",{"facility":136,"status":35,"city":137,"state":138,"zip":139,"country":97,"countryCode":98,"cosmosGeoPoint":140,"geoPoint":144,"contacts":145},"University Hospital Southampton NHS Foundation Trust","Southampton","Hampshire","SO16 6YD",{"type":42,"coordinates":141},[142,143],-1.40428,50.90395,{"lat":143,"lon":142},[146,148],{"name":10,"role":27,"phone":147,"phoneExt":10,"email":10},"023 8077 7222",{"name":149,"role":52,"phone":10,"phoneExt":10,"email":10},"Annamaria Kiss-csenki",{"facility":151,"status":35,"city":152,"state":153,"zip":154,"country":97,"countryCode":98,"cosmosGeoPoint":155,"geoPoint":159,"contacts":160},"Nottingham University Hospitals Trust","Nottingham","Nottinghamshire","NG5 1PB",{"type":42,"coordinates":156},[157,158],-1.15047,52.9536,{"lat":158,"lon":157},[161,163],{"name":10,"role":27,"phone":162,"phoneExt":10,"email":10},"0115 969 1169",{"name":164,"role":52,"phone":10,"phoneExt":10,"email":10},"Saam Sedehizadeh",{"facility":166,"status":35,"city":167,"state":168,"zip":169,"country":97,"countryCode":98,"cosmosGeoPoint":170,"geoPoint":174,"contacts":175},"The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust","Oswestry","Shropshire","SY10 7AG",{"type":42,"coordinates":171},[172,173],-3.05497,52.86195,{"lat":173,"lon":172},[176,178],{"name":10,"role":27,"phone":177,"phoneExt":10,"email":10},"01691 404000",{"name":179,"role":52,"phone":10,"phoneExt":10,"email":10},"Tracey Willis",{"facility":181,"status":35,"city":182,"state":183,"zip":184,"country":97,"countryCode":98,"cosmosGeoPoint":185,"geoPoint":189,"contacts":190},"Sheffield Teaching Hospitals NHS Foundation Trust","Sheffield","South Yorkshire","S10 2SB",{"type":42,"coordinates":186},[187,188],-1.4659,53.38297,{"lat":188,"lon":187},[191,193],{"name":10,"role":27,"phone":192,"phoneExt":10,"email":10},"0114 271 7000",{"name":194,"role":52,"phone":10,"phoneExt":10,"email":10},"Channa Hewamadduma",{"facility":196,"status":35,"city":197,"state":198,"zip":199,"country":97,"countryCode":98,"cosmosGeoPoint":200,"geoPoint":204,"contacts":205},"The Newcastle upon Tyne Hospitals NHS Foundation Trust","Newcastle upon Tyne","Tyne and Wear","NE7 7ND",{"type":42,"coordinates":201},[202,203],-1.61396,54.97328,{"lat":203,"lon":202},[206,208],{"name":10,"role":27,"phone":207,"phoneExt":10,"email":10},"0191 233 6161",{"name":209,"role":52,"phone":10,"phoneExt":10,"email":10},"Chiara Marini-Bettolo",{"facility":211,"status":35,"city":212,"state":213,"zip":214,"country":97,"countryCode":98,"cosmosGeoPoint":215,"geoPoint":219,"contacts":220},"University Hospitals Birmingham NHS Foundation Trust","Birmingham","West Midlands","B15 2GW",{"type":42,"coordinates":216},[217,218],-1.89983,52.48142,{"lat":218,"lon":217},[221,223],{"name":10,"role":27,"phone":222,"phoneExt":10,"email":10},"(0121) 432 3232",{"name":224,"role":52,"phone":10,"phoneExt":10,"email":10},"Nicholas Davies",{"facility":226,"status":35,"city":227,"state":10,"zip":228,"country":97,"countryCode":98,"cosmosGeoPoint":229,"geoPoint":233,"contacts":234},"North Bristol NHS Trust","Bristol","BS10 5NB",{"type":42,"coordinates":230},[231,232],-2.59665,51.45523,{"lat":232,"lon":231},[235,237],{"name":10,"role":27,"phone":236,"phoneExt":10,"email":10},"0117 950 5050",{"name":238,"role":52,"phone":10,"phoneExt":10,"email":10},"Andria Merrison",{"type":240,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100499938","a-study-to-learn-how-nusinersen-spinraza-affects-participants-with-spinal-muscular-atrophy-sma-who-took-it-before-or-during-pregnancy-and-about-the-health-of-their-babies-100499938",false,"NCT05789758","A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies","Spinraza (Nusinersen) SMA Pregnancy Exposure Study Within Existing SMA Registries","Key Inclusion Criteria:\n\n* Participant who is currently pregnant (or was pregnant during the relevant exposure window) and enrolled in the United States (US) network of the ISMAR registry, the United Kingdom (UK) Adult SMA REACH, or the Germany, Austria, or Switzerland network of the SMArtCARE registry\n* Genetic documentation of spinal muscular atrophy linked to chromosome 5q (5q SMA)\n* Documentation that the participant was exposed to nusinersen up to 14 months prior to the first day of their LMP before conception, 14.5 months before conception, and\u002For at any time during their pregnancy\n\nKey Exclusion Criteria:\n\n* Treatment with risdiplam at any time from the first day of their LMP, 2 weeks prior to the date of conception (approximately 5 half-lives), and\u002For plans to receive treatment with risdiplam during pregnancy\n\nNOTE: Other protocol defined Inclusion\u002FExclusion criteria may apply","FEMALE","18 Years","54 Years",{"count":252,"type":253},20,"ESTIMATED","2 Years","OBSERVATIONAL","In this study, researchers will know more about the effects of nusinersen, also known as Spinraza®, in pregnant participants with spinal muscular atrophy, also known as SMA. This is a drug available for doctors to prescribe for people with SMA. Due to the current treatment options that exist, people with SMA may now reach the age where they can become pregnant. But, there is not enough information known yet about what the effects of nusinersen may be on pregnant people with SMA or on their babies.\n\nThis is known as an \"observational\" study, which collects health information about study participants without changing their medical care. The pregnant participants for this study will be found using 3 different groups of SMA study research centers:\n\n* ISMAR-US (International SMA Registry in the United States)\n* UK Adult SMA-REACH (Adult SMA Research and Clinical Hub in the United Kingdom)\n* SMArtCARE (Austria, Germany, and Switzerland)\n\nThe main goal of this study is to collect birth and health information from 3 groups of participants and their babies. These groups are:\n\n* Those who received nusinersen 14 months before the first day of their last period before getting pregnant\n* Those who received nusinersen 14.5 months before the day they got pregnant\n* Those who received nusinersen during any time in their pregnancy\n\nThe main questions researchers want to learn about in this study are:\n\n* Loss of pregnancy overall\n* Loss of pregnancy before the baby was 20 weeks old\n* Loss of pregnancy after the baby becomes 20 weeks old\n* Live births\n* Loss of the baby after birth\n* Babies who have problems in their body that develop during pregnancy\n* Babies who are small for their age while in the participant's uterus\n* Pregnancy that happens outside of the uterus\n* How many participants die during pregnancy, while the baby is being born, and up to 12 weeks after delivering the baby\n* Babies who develop problems in their body after birth\n\nResearchers will also compare this information to people without SMA who have not received nusinersen.\n\nThis study will be done as follows:\n\n* Information will start being collected when the participant decides to join the study.\n* Participants will be contacted at each trimester (about every 3 months) to learn about their health and pregnancy.\n* Participants' doctors will be contacted at each trimester, when the participants are about 6 or 7 months pregnant, and about 4 weeks after the delivery of the baby.\n* The babies' doctors will be contacted when the baby is 1, 2, 6, 12, 18, and 24 months old.\n* Each participant will be in the study until the end of their pregnancy and for up to 12 weeks after delivery. Each baby will be in the study for up to 2 years after birth.\n* The study overall will last at least 10 years from when the first participant joins the study.",[258],"Muscular Atrophy, Spinal","2026-03-06",{"date":261,"type":262},"2026-03-09","ACTUAL",{"date":264,"type":262},"2023-12-15",{"date":266,"type":253},"2033-10-31",{"name":5,"class":6},14]